Logo image of MCHPP

MICROCHIP TECHNOLOGY INC - MCHP 7 1/2 03/15/28 (MCHPP) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:MCHPP - US5950173022

61.07 USD
-0.19 (-0.31%)
Last: 12/9/2025, 8:13:37 PM
61.124 USD
+0.05 (+0.09%)
After Hours: 12/9/2025, 8:13:37 PM
Fundamental Rating

4

Overall MCHPP gets a fundamental rating of 4 out of 10. We evaluated MCHPP against 112 industry peers in the Semiconductors & Semiconductor Equipment industry. MCHPP has an average financial health and profitability rating. While showing a medium growth rate, MCHPP is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

MCHPP had positive earnings in the past year.
MCHPP had a positive operating cash flow in the past year.
Of the past 5 years MCHPP 4 years were profitable.
In the past 5 years MCHPP always reported a positive cash flow from operatings.
MCHPP Yearly Net Income VS EBIT VS OCF VS FCFMCHPP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

1.2 Ratios

MCHPP has a Return On Assets of -1.69%. This is comparable to the rest of the industry: MCHPP outperforms 41.96% of its industry peers.
MCHPP has a Return On Equity (-3.66%) which is comparable to the rest of the industry.
The Return On Invested Capital of MCHPP (0.91%) is comparable to the rest of the industry.
MCHPP had an Average Return On Invested Capital over the past 3 years of 11.93%. This is in line with the industry average of 10.82%.
The 3 year average ROIC (11.93%) for MCHPP is well above the current ROIC(0.91%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -1.69%
ROE -3.66%
ROIC 0.91%
ROA(3y)8.56%
ROA(5y)7.14%
ROE(3y)20.99%
ROE(5y)18.26%
ROIC(3y)11.93%
ROIC(5y)10.28%
MCHPP Yearly ROA, ROE, ROICMCHPP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

1.3 Margins

Looking at the Operating Margin, with a value of 3.68%, MCHPP is in line with its industry, outperforming 55.36% of the companies in the same industry.
In the last couple of years the Operating Margin of MCHPP has declined.
MCHPP has a better Gross Margin (54.06%) than 71.43% of its industry peers.
MCHPP's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.68%
PM (TTM) N/A
GM 54.06%
OM growth 3Y-32.35%
OM growth 5Y-8.3%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.92%
GM growth 5Y-1.82%
MCHPP Yearly Profit, Operating, Gross MarginsMCHPP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), MCHPP is creating some value.
Compared to 1 year ago, MCHPP has more shares outstanding
MCHPP has more shares outstanding than it did 5 years ago.
MCHPP has a better debt/assets ratio than last year.
MCHPP Yearly Shares OutstandingMCHPP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
MCHPP Yearly Total Debt VS Total AssetsMCHPP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

MCHPP has an Altman-Z score of 3.50. This indicates that MCHPP is financially healthy and has little risk of bankruptcy at the moment.
MCHPP's Altman-Z score of 3.50 is in line compared to the rest of the industry. MCHPP outperforms 50.00% of its industry peers.
The Debt to FCF ratio of MCHPP is 7.13, which is on the high side as it means it would take MCHPP, 7.13 years of fcf income to pay off all of its debts.
MCHPP has a Debt to FCF ratio of 7.13. This is comparable to the rest of the industry: MCHPP outperforms 51.79% of its industry peers.
A Debt/Equity ratio of 0.80 indicates that MCHPP is somewhat dependend on debt financing.
MCHPP has a Debt to Equity ratio of 0.80. This is amonst the worse of the industry: MCHPP underperforms 81.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF 7.13
Altman-Z 3.5
ROIC/WACC0.09
WACC10.16%
MCHPP Yearly LT Debt VS Equity VS FCFMCHPP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.3 Liquidity

MCHPP has a Current Ratio of 2.25. This indicates that MCHPP is financially healthy and has no problem in meeting its short term obligations.
With a Current ratio value of 2.25, MCHPP is not doing good in the industry: 68.75% of the companies in the same industry are doing better.
A Quick Ratio of 1.20 indicates that MCHPP should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.20, MCHPP is not doing good in the industry: 81.25% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 2.25
Quick Ratio 1.2
MCHPP Yearly Current Assets VS Current LiabilitesMCHPP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

4

3. Growth

3.1 Past

The earnings per share for MCHPP have decreased strongly by -64.77% in the last year.
The earnings per share for MCHPP have been decreasing by -14.29% on average. This is quite bad
MCHPP shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -23.36%.
MCHPP shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.55% yearly.
EPS 1Y (TTM)-64.77%
EPS 3Y-34.42%
EPS 5Y-14.29%
EPS Q2Q%-23.91%
Revenue 1Y (TTM)-23.36%
Revenue growth 3Y-13.58%
Revenue growth 5Y-3.55%
Sales Q2Q%-2.01%

3.2 Future

Based on estimates for the next years, MCHPP will show a very strong growth in Earnings Per Share. The EPS will grow by 29.55% on average per year.
MCHPP is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.85% yearly.
EPS Next Y12.78%
EPS Next 2Y39.7%
EPS Next 3Y41.47%
EPS Next 5Y29.55%
Revenue Next Year3.21%
Revenue Next 2Y10.83%
Revenue Next 3Y13.73%
Revenue Next 5Y9.85%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MCHPP Yearly Revenue VS EstimatesMCHPP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
MCHPP Yearly EPS VS EstimatesMCHPP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

3

4. Valuation

4.1 Price/Earnings Ratio

MCHPP is valuated quite expensively with a Price/Earnings ratio of 65.67.
The rest of the industry has a similar Price/Earnings ratio as MCHPP.
MCHPP is valuated expensively when we compare the Price/Earnings ratio to 26.28, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 24.07 indicates a rather expensive valuation of MCHPP.
Based on the Price/Forward Earnings ratio, MCHPP is valued a bit cheaper than the industry average as 76.79% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of MCHPP to the average of the S&P500 Index (23.52), we can say MCHPP is valued inline with the index average.
Industry RankSector Rank
PE 65.67
Fwd PE 24.07
MCHPP Price Earnings VS Forward Price EarningsMCHPP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MCHPP is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MCHPP indicates a somewhat cheap valuation: MCHPP is cheaper than 71.43% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 43.75
EV/EBITDA 43.82
MCHPP Per share dataMCHPP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
MCHPP's earnings are expected to grow with 41.47% in the coming years. This may justify a more expensive valuation.
PEG (NY)5.14
PEG (5Y)N/A
EPS Next 2Y39.7%
EPS Next 3Y41.47%

4

5. Dividend

5.1 Amount

MCHPP has a Yearly Dividend Yield of 2.81%.
Compared to an average industry Dividend Yield of 2.09, MCHPP pays a better dividend. On top of this MCHPP pays more dividend than 93.75% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.31, MCHPP pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.81%

5.2 History

On average, the dividend of MCHPP grows each year by 20.15%, which is quite nice.
MCHPP does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)20.15%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

MCHPP has negative earnings and hence a negative payout ratio. The dividend may be in danger.
MCHPP's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-421.71%
EPS Next 2Y39.7%
EPS Next 3Y41.47%
MCHPP Yearly Income VS Free CF VS DividendMCHPP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

MICROCHIP TECHNOLOGY INC - MCHP 7 1/2 03/15/28

NASDAQ:MCHPP (12/9/2025, 8:13:37 PM)

After market: 61.124 +0.05 (+0.09%)

61.07

-0.19 (-0.31%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)02-04 2026-02-04/amc
Inst Owners98.37%
Inst Owner ChangeN/A
Ins Owners1.93%
Ins Owner ChangeN/A
Market Cap33.01B
Revenue(TTM)4.21B
Net Income(TTM)-245.10M
Analysts79.39
Price Target68.98 (12.95%)
Short Float %0.15%
Short Ratio5.59
Dividend
Industry RankSector Rank
Dividend Yield 2.81%
Yearly Dividend1.81
Dividend Growth(5Y)20.15%
DP-421.71%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.19%
Min EPS beat(2)2.58%
Max EPS beat(2)11.8%
EPS beat(4)3
Avg EPS beat(4)-2.68%
Min EPS beat(4)-27.71%
Max EPS beat(4)11.8%
EPS beat(8)5
Avg EPS beat(8)-0.82%
EPS beat(12)5
Avg EPS beat(12)-1.03%
EPS beat(16)7
Avg EPS beat(16)-0.46%
Revenue beat(2)0
Avg Revenue beat(2)-0.83%
Min Revenue beat(2)-1.6%
Max Revenue beat(2)-0.05%
Revenue beat(4)0
Avg Revenue beat(4)-1.89%
Min Revenue beat(4)-4.74%
Max Revenue beat(4)-0.05%
Revenue beat(8)0
Avg Revenue beat(8)-1.9%
Revenue beat(12)0
Avg Revenue beat(12)-1.88%
Revenue beat(16)0
Avg Revenue beat(16)-1.69%
PT rev (1m)-4.2%
PT rev (3m)-4.71%
EPS NQ rev (1m)-2.66%
EPS NQ rev (3m)-4.93%
EPS NY rev (1m)-2.33%
EPS NY rev (3m)-3.31%
Revenue NQ rev (1m)-1.44%
Revenue NQ rev (3m)-3.48%
Revenue NY rev (1m)-2.05%
Revenue NY rev (3m)-2.14%
Valuation
Industry RankSector Rank
PE 65.67
Fwd PE 24.07
P/S 7.84
P/FCF 43.75
P/OCF 39.24
P/B 4.93
P/tB N/A
EV/EBITDA 43.82
EPS(TTM)0.93
EY1.52%
EPS(NY)2.54
Fwd EY4.15%
FCF(TTM)1.4
FCFY2.29%
OCF(TTM)1.56
OCFY2.55%
SpS7.79
BVpS12.39
TBVpS-4.01
PEG (NY)5.14
PEG (5Y)N/A
Graham Number16.1
Profitability
Industry RankSector Rank
ROA -1.69%
ROE -3.66%
ROCE 1.16%
ROIC 0.91%
ROICexc 0.93%
ROICexgc 2.84%
OM 3.68%
PM (TTM) N/A
GM 54.06%
FCFM 17.91%
ROA(3y)8.56%
ROA(5y)7.14%
ROE(3y)20.99%
ROE(5y)18.26%
ROIC(3y)11.93%
ROIC(5y)10.28%
ROICexc(3y)12.2%
ROICexc(5y)10.52%
ROICexgc(3y)48.65%
ROICexgc(5y)43.88%
ROCE(3y)15.1%
ROCE(5y)13.02%
ROICexgc growth 3Y-44.39%
ROICexgc growth 5Y-17.88%
ROICexc growth 3Y-40.07%
ROICexc growth 5Y-9.14%
OM growth 3Y-32.35%
OM growth 5Y-8.3%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.92%
GM growth 5Y-1.82%
F-Score3
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF 7.13
Debt/EBITDA 6.16
Cap/Depr 12.08%
Cap/Sales 2.06%
Interest Coverage 250
Cash Conversion 96.37%
Profit Quality N/A
Current Ratio 2.25
Quick Ratio 1.2
Altman-Z 3.5
F-Score3
WACC10.16%
ROIC/WACC0.09
Cap/Depr(3y)32.64%
Cap/Depr(5y)27.66%
Cap/Sales(3y)4.12%
Cap/Sales(5y)3.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-64.77%
EPS 3Y-34.42%
EPS 5Y-14.29%
EPS Q2Q%-23.91%
EPS Next Y12.78%
EPS Next 2Y39.7%
EPS Next 3Y41.47%
EPS Next 5Y29.55%
Revenue 1Y (TTM)-23.36%
Revenue growth 3Y-13.58%
Revenue growth 5Y-3.55%
Sales Q2Q%-2.01%
Revenue Next Year3.21%
Revenue Next 2Y10.83%
Revenue Next 3Y13.73%
Revenue Next 5Y9.85%
EBIT growth 1Y-86.35%
EBIT growth 3Y-41.54%
EBIT growth 5Y-11.55%
EBIT Next Year54.95%
EBIT Next 3Y42.38%
EBIT Next 5Y25.08%
FCF growth 1Y-76.11%
FCF growth 3Y-32.16%
FCF growth 5Y-12.16%
OCF growth 1Y-76.62%
OCF growth 3Y-31.89%
OCF growth 5Y-10.27%

MICROCHIP TECHNOLOGY INC - MCHP 7 1/2 03/15/28 / MCHPP FAQ

Can you provide the ChartMill fundamental rating for MICROCHIP TECHNOLOGY INC - MCHP 7 1/2 03/15/28?

ChartMill assigns a fundamental rating of 4 / 10 to MCHPP.


What is the valuation status for MCHPP stock?

ChartMill assigns a valuation rating of 3 / 10 to MICROCHIP TECHNOLOGY INC - MCHP 7 1/2 03/15/28 (MCHPP). This can be considered as Overvalued.


How profitable is MICROCHIP TECHNOLOGY INC - MCHP 7 1/2 03/15/28 (MCHPP) stock?

MICROCHIP TECHNOLOGY INC - MCHP 7 1/2 03/15/28 (MCHPP) has a profitability rating of 4 / 10.


What is the valuation of MICROCHIP TECHNOLOGY INC - MCHP 7 1/2 03/15/28 based on its PE and PB ratios?

The Price/Earnings (PE) ratio for MICROCHIP TECHNOLOGY INC - MCHP 7 1/2 03/15/28 (MCHPP) is 65.67 and the Price/Book (PB) ratio is 4.93.


Can you provide the expected EPS growth for MCHPP stock?

The Earnings per Share (EPS) of MICROCHIP TECHNOLOGY INC - MCHP 7 1/2 03/15/28 (MCHPP) is expected to grow by 12.78% in the next year.